When urologist Peter Carroll, MD, MPH, did his residency at UCSF 30 years ago, cancer was “a word that was whispered,” a knowledgeable patient was someone who just followed doctor’s orders and oftentimes a diagnosis wasn’t made until disease was advanced.
August 24, 2014
March 17, 2014
One of the world’s preeminent cancer scientists, Alan Ashworth, PhD, FRS, has been appointed the new director of the UCSF Helen Diller Family Comprehensive Cancer Center.
February 04, 2014
Researchers are harnessing the power of the body's natural defenses to fight deadly cancers, and the treatment appears to be powerful, effective and long-lasting.
December 05, 2013
UCSF has been awarded a major federal grant to “transform and revolutionize” the treatment of prostate cancer, the second most common form of cancer among American men.
May 08, 2013
A new genomic test can help predict whether men are more likely to harbor an aggressive form of prostate cancer, according to a new UCSF study.
December 11, 2012
President Barack Obama announced his intent to nominate UCSF's Mack Roach, who is recognized as a major authority on the treatment of prostate cancer, to the National Cancer Advisory Board.
February 22, 2012
Uncovering the network of genes regulated by a crucial molecule involved in cancer called mTOR, which controls protein production inside cells, researchers at UCSF have discovered how a protein “master regulator” goes awry, leading to metastasis, the fatal step of cancer.
February 01, 2012
Scientists at UCSF have identified nearly 200 genes in the healthy prostate tissue of men with low-grade prostate cancer that may help explain how physical activity improves survival from the disease.
October 25, 2011
New studies of vitamin supplements, prostate cancer risk in men and mortality in women have yielded disappointing results. Some researchers remain optimistic about identifying dietary and lifestyle interventions that are beneficial to health.
October 19, 2011
A rekindled controversy over the use of PSA screening to help detect prostate cancer highlights the different perspectives physicians may take in framing issues, evaluating studies and deciding on best practices.